QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
NYSE:VAR

Varian Medical Systems (VAR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$177.07
$177.07
50-Day Range
$176.53
$177.29
52-Week Range
$103.67
$177.38
Volume
N/A
Average Volume
746,779 shs
Market Capitalization
$16.26 billion
P/E Ratio
60.43
Dividend Yield
N/A
Price Target
N/A

Varian Medical Systems MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-0.79
Upright™ Environmental Score
News Sentiment
0.00mentions of Varian Medical Systems in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.08%
From $5.20 to $5.88 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.24 out of 5 stars

Medical Sector

750th out of 914 stocks

Electromedical Equipment Industry

15th out of 20 stocks

VAR stock logo

About Varian Medical Systems Stock (NYSE:VAR)

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.

VAR Stock News Headlines

Raigmore Hospital in Scotland selects RayCare
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
Veterinary Disposables Global Market Report 2024
Best Mobile Medical Alert Systems Of 2024
The 5 Best Medical Alert Watches of 2024
Buddy system part of holistic cancer care
A Complete Guide to Your Vagus Nerve
See More Headlines
Receive VAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Varian Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/25/2021
Today
4/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
Health Care Equipment
CUSIP
92220P10
Fax
N/A
Employees
10,000
Year Founded
1948

Profitability

Net Income
$269.20 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.17 billion
Cash Flow
$5.07 per share
Book Value
$22.92 per share

Miscellaneous

Free Float
N/A
Market Cap
$16.26 billion
Optionable
Optionable
Beta
1.06

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Should I Buy Varian Medical Systems Stock? VAR Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Varian Medical Systems, Inc.:

  • Varian Medical Systems, Inc. has a strong presence in the electromedical equipment industry, specializing in health care equipment, which indicates stability and growth potential in a crucial sector.
  • Varian's focus on developing advanced medical devices and software products for treating cancer worldwide positions the company at the forefront of cutting-edge technology in the healthcare industry.
  • With Ms. Kolleen T. Kennedy leading the Oncology Systems segment as Executive Vice President and President, Varian benefits from experienced leadership with a background in medical physics and radiation oncology, ensuring strategic growth and innovation.
  • Recent strategic agreements with McKesson Corp. and Siemens AG demonstrate Varian's commitment to expanding its market reach and enhancing its product offerings, potentially leading to increased revenue and market share.
  • Investors may find Varian Medical Systems, Inc. attractive due to its consistent financial performance and stock price stability, providing a reliable investment opportunity in the healthcare sector.

Cons

Investors should be bearish about investing in Varian Medical Systems, Inc. for these reasons:

  • Varian's dependency on the healthcare industry for revenue exposes the company to regulatory changes, market fluctuations, and healthcare policy shifts, which could impact financial performance and investor returns.
  • The competitive landscape in the electromedical equipment sector, especially in cancer treatment technologies, poses a challenge to Varian's market position and may require continuous innovation and investment to stay ahead of competitors.
  • While Varian's focus on proton therapy for cancer treatment is innovative, the high costs associated with proton therapy systems and limited accessibility may hinder widespread adoption, affecting revenue growth potential.
  • Fluctuations in global economic conditions and healthcare spending trends could impact Varian's sales and profitability, making the company susceptible to external factors beyond its control.
  • Investors should carefully monitor Varian Medical Systems, Inc.'s financial reports, market developments, and competitive landscape to make informed decisions about the company's long-term growth prospects and investment viability.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, April 11, 2024. Please send any questions or comments about these Varian Medical Systems pros and cons to contact@marketbeat.com.

VAR Stock Analysis - Frequently Asked Questions

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) issued its earnings results on Monday, January, 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.04. The medical equipment provider earned $778.80 million during the quarter, compared to analyst estimates of $832.97 million. Varian Medical Systems had a trailing twelve-month return on equity of 18.45% and a net margin of 8.50%. The firm's quarterly revenue was down 6.1% on a year-over-year basis. During the same quarter last year, the business posted $1.16 EPS.

What is Dow R. Wilson's approval rating as Varian Medical Systems' CEO?

317 employees have rated Varian Medical Systems Chief Executive Officer Dow R. Wilson on Glassdoor.com. Dow R. Wilson has an approval rating of 92% among the company's employees. This puts Dow R. Wilson in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), CVS Health (CVS), Gilead Sciences (GILD), Intel (INTC), Visa (V), Coca-Cola (KO) and AbbVie (ABBV).

Does Varian Medical Systems have any subsidiaries?
The following companies are subsidiares of Varian Medical Systems: Accel Instruments GmbH, American Institute of Pathology and Laboratory Sciences Private Limited, Applied Computational Technologies, Argus Software, Artmed Healthcare Private Limited, Asiri AOI Cancer Center (Private) Ltd., Bakerville Investments Sp. zo. o, Bio-Imaging Research, Boston Scientific, CTSI, CTSI, CTSI (Mauritius) Limited, Calypso Medical, Cancer Treatment Services Hyderabad Private Limited, Candela's radiotherapy business, Centella Therapeutics Inc., Claymount Americas Corporation, Claymount Assemblies B.V., Claymount Assemblies Philippines Inc., Claymount High Voltage Technologies (Beijing) Co. Ltd., Claymount International AG, Claymount Switzerland AG, Claymount Technologies, Claymount Technologies Group B.V., CyberHeart Inc., D3 Oncology Inc., Endocare, Endocare Inc., Fang Chi Health Management Co. Ltd., Hangzhou Alicon Pharmaceutical Technology Co. Ltd., Hong Tai Health Management Co. Ltd., IKOEmed, IMPAC Medical System, Infimed, Jiangsu Varian Medical Systems Co. Ltd., MDS Nordion's - (HDR) Brachytherapy Business, MRW GmbH, Mansfield Insurance Company, MeVis Medical Solutions AG, Mobius Medical Systems, Mobius Medical Systems Holdings LLC, Mobius Medical Systems LP, Monarch Capital Limited, Multimedia Medical Systems - Cancer Treatment Planning Systems Division, New Century Health Care Corporation, OpTx Corp, Page Mill Corporation, Pan-Pacific Enterprises, PerkinElmer's Medical Imaging Business, Scion Medical Limited, Scion Medical Technologies (Shanghai) Ltd., Sigma Micro Informatique Conseil, Talent Choice Investment Limited, Transpire, TrueBeam Systems, VMS Deutschland Holdings G.m.b.H., VMS Kenya Ltd, Varex Imagens Brasil Holdings Ltda., Varex Imaging, Varex Imaging Deutschland GmbH, Varex Imaging France SARL, Varex Imaging Holdings Inc., Varex Imaging International Holdings B.V., Varex Imaging Investments B.V., Varex Imaging Italia Srl, Varex Imaging UK Limited, Varian BioSynergy Inc., Varian FSC B.V., Varian Medical Systems (China) Co. Ltd., Varian Medical Systems (RUS) LLC, Varian Medical Systems Africa (Pty) Ltd., Varian Medical Systems Africa Holdings Inc., Varian Medical Systems Algeria Spa, Varian Medical Systems Arabia Commercial Limited, Varian Medical Systems Australasia Pty Ltd., Varian Medical Systems Belgium N.V., Varian Medical Systems Brasil Limitada, Varian Medical Systems Canada Holdings Inc., Varian Medical Systems Canada Inc., Varian Medical Systems Deutschland G.m.b.H., Varian Medical Systems Deutschland Holdings G.m.b.H., Varian Medical Systems Finland OY, Varian Medical Systems France, Varian Medical Systems Gesellschaft m.b.H., Varian Medical Systems Haan G.m.b.H., Varian Medical Systems Hungary Kft, Varian Medical Systems Iberica S.L., Varian Medical Systems Imaging Laboratory Gmbh, Varian Medical Systems India Pvt. Ltd., Varian Medical Systems India Software Pvt. Ltd., Varian Medical Systems International (India) Pvt. Ltd., Varian Medical Systems International A.G., Varian Medical Systems International Holdings Inc., Varian Medical Systems Italia S.p.A., Varian Medical Systems K.K., Varian Medical Systems Korea Inc., Varian Medical Systems Latin America Ltd., Varian Medical Systems Malaysia Sdn. Bhd., Varian Medical Systems Mauritius Ltd., Varian Medical Systems München GmbH, Varian Medical Systems Nederland B.V., Varian Medical Systems Nederland Finance B.V., Varian Medical Systems Netherlands Holdings Inc., Varian Medical Systems Pacific Inc., Varian Medical Systems Particle Therapy GmbH, Varian Medical Systems Philippines Inc., Varian Medical Systems Poland Sp. zo. o, Varian Medical Systems Puerto Rico LLC, Varian Medical Systems Scandinavia AS, Varian Medical Systems Taiwan Co. Ltd., Varian Medical Systems Trading (Beijing) Co. Ltd., Varian Medical Systems UK Holdings Limited, Varian Medical Systems UK Ltd., Varian Medical Systems Vietnam Company Limited, Varian Medical Systems de Mexico S de RL de CV, Varian Philippines Ltd., Varinak Bulgaria LTD, Varinak Europe SRL, Varinak Oncology Systems, Velocity Medical Solutions, Vertice Investment Limited, VivaRay Inc., Zmed Inc., and dpiX.
Read More
This page (NYSE:VAR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners